BESURE TESTING INC.
NPI 1447855952
Clinical Medical Laboratory in Greensboro, NC

NPI Status: Active since December 02, 2020

Contact Information

204 MUIRS CHAPEL RD STE 342
GREENSBORO, NC
ZIP 27410
Phone: (336) 740-2277

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • CLIA Number: 34D2187132
  • CLIA Cert. Type: Mobile Laboratory
  • CLIA Exp. Date: 06-24-2026

About BESURE TESTING INC.

This page provides the complete NPI Profile along with additional information for Besure Testing Inc., a provider established in Greensboro, North Carolina operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1447855952 assigned on December 2020. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 4 years ago. The provider's former legal business name is Cv-19. The authorized official of this NPI record is Henry Grause (Ceo)

NPI
1447855952
Provider Legal Name
BESURE TESTING INC.
Other Organization Name
CV-19
Other Name Type
Former Legal Business Name (4)
Entity Type
Organization
Location Address
204 MUIRS CHAPEL RD STE 342 GREENSBORO, NC 27410
Location Phone
(336) 740-2277
Mailing Address
204 MUIRS CHAPEL RD STE 342 GREENSBORO, NC 27410
Mailing Phone
(336) 740-2277
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
12-02-2020
Last Update Date
02-15-2022
Code Navigator

Establishments like Besure Testing Inc. are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

HENRY GRAUSE

Authorized Official Title
CEO
Authorized Official Phone
(703) 629-8300

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Detection test by immunoassay with direct visual observation for influenza virus

This is a test that identifies the influenza virus in your body. It works by using an immunoassay, a method that detects the presence of the virus through an immune response. The results are directly observable, making it a quick and efficient way to diagnose flu.

This service was performed 25 times for 12 patients

Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19)

This is a test to detect COVID-19, the virus causing severe respiratory illness. It uses a method called immunoassay, which identifies the virus by its unique proteins. The test is directly observed for accuracy. It helps determine if you're currently infected.

This service was performed 2,651 times for 195 patients

Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source

Specimen collection for SARS-CoV-2, the virus causing COVID-19, involves taking a sample from the nose or throat using a swab. This sample is then analyzed in a lab to detect the presence of the virus. It's a crucial step in diagnosing COVID-19.

This service was performed 1,846 times for 185 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
34D2187132
Facility Type
Mobile Laboratory
Certificate Effective Date
June 25, 2024
Certificate Expiration Date
June 24, 2026
Laboratory Director
HENRY GRAUSE
Certificate Type
Certificate of Waiver
Certificate Type Description
This CLIA certificate is issued to Besure Testing Inc. to perform only waived tests. CLIA defines waived tests as simple tests with a low risk for an incorrect result. Waived tests include certain tests listed in CLIA regulations, tests cleared by the FDA for home use and tests approved by the FDA for waived status and that meet CLIA waiver criteria.

Reviews for BESURE TESTING INC.

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1447855952, we treat the final digit (2) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 68. The final step is to find the difference between that total and the next multiple of ten (70 - 68 = 2).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
4
Unchanged
Pos 3
4
Doubled → 8
Pos 4
7
Unchanged
Pos 5
8
Doubled → 16 → 1 + 6
Pos 6
5
Unchanged
Pos 7
5
Doubled → 10 → 1 + 0
Pos 8
9
Unchanged
Pos 9
5
Doubled → 10 → 1 + 0
Check
2
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 4 → 8 8 → 16 → 7 5 → 10 → 1 5 → 10 → 1

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 4 + 8 + 7 + 1 + 6 + 5 + 1 + 0 + 9 + 1 + 0 + 24 = 68

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 68 is 70. The difference is the calculated check digit.

70 - 68 = 2
This NPI is valid
The calculated check digit is 2, which matches the last digit of 1447855952.

Other Providers at the Same Location


The following 1 provider is registered at the same or a nearby location.

Clinic/Center (Radiology, Mammography)
204 MUIRS CHAPEL RD STE 342
GREENSBORO, NC 27410

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1447855952, enumerated as an "organization" on December 02, 2020.

The provider is located at 204 MUIRS CHAPEL RD STE 342 GREENSBORO, NC 27410 and the phone number is (336) 740-2277.

Clinical Medical Laboratory with taxonomy code 291U00000X.